5alpha-Reductase: History and Clinical Importance
January 2004
in “
PubMed
”
TLDR 5alpha-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT, offering symptom relief and potential future uses.
The document discussed the clinical importance of 5alpha-reductase (5AR) inhibitors, such as finasteride and dutasteride, in treating benign prostatic hyperplasia (BPH) by inhibiting dihydrotestosterone (DHT), which is crucial for prostatic growth and male pattern baldness. These inhibitors led to prostatic shrinkage and symptom relief without the side effects of traditional therapies and potentially altered BPH progression. The document also noted the potential of dutasteride in reducing prostate cancer incidence, as shown by a clinical trial. Additionally, the enzyme 5AR was significant in understanding conditions like male pseudohermaphroditism and androgenic alopecia, providing insights into its genetic and physiological impact on male health.